Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML)
- Status
- COMPLETED
- Phase
- N/A
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AZD6738 for Patients With Progressive MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL
- Status
- TERMINATED
- Phase
- PHASE2
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Status
- RECRUITING
- Phase
- N/A
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
- Status
- COMPLETED
- Phase
- PHASE4
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies
- Status
- UNKNOWN
- Phase
- N/A
Managed Access Programs for CTL019, Tisagenlecleucel
- Status
- AVAILABLE
- Phase
- N/A
Efficacy of FLAG Regimen for the Treatment of Patients With AML
- Status
- UNKNOWN
- Phase
- N/A
A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric Population
- Status
- UNKNOWN
- Phase
- NA
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
WB-EMS and Nutrition in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA